MarketInOut Stock Screener Log In | Sign Up

Pfizer Inc

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/28/2026 09:52
Pfizer Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization153,230 mln
Float5,695 mln
Earnings Date11/03/2026

EPS

0.65
Stretched

P / E

40.95
High premium

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.63
Likely reliable

Relative Strength

69 / 100
Outperforming

Debt / Equity

0.74
Moderate leverage

Business Description

Pfizer is one of the world's largest pharmaceutical companies, researching, producing, and selling a broad range of medicines and vaccines across the United States and globally. Its portfolio spans treatments for heart disease, migraines, cancer, rare conditions, and infectious diseases, along with a growing line of biosimilar medicines. Founded in 1849 and based in New York, the company also works alongside several major healthcare and biotechnology partners to develop new therapies.

Key Fundamentals

EPS0.65
P/E40.95
ROE4.89
RPS9.98
ROIC9.34
ROA2.10
Interest Cover6.27
EBITDA, mln11,549
EV / EBITDA15.97
EV / EBIT31.20
Revenue, mln54,617
EV / Revenue3.38

Quote Details

Last 26.64
Change -0.01 (-0.04%)
Open 26.67
Volume 1,105
Turnover 29,437
Average Volume 37,672

Financial Ratios

Pre-Tax Profit Margin7
Leverage Ratio2.36
Current Ratio1.27
Price / Book1.93
Price / Cash Flow12.77
Price / Free Cash Flow15.11
Debt / Equity0.74
Price / Sales2.60
PEG Ratio13.93

Financial Strength

Altman Z-Score2.11
Piotroski F-Score 6 / 9
Beneish M-Score-2.63
Price to Intrinsic Value0.78
Shiller PE Ratio10.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.38% 57 / 100   
1 Month 6.65% 85 / 100   
2 Months 23.16% 96 / 100   
6 Months 23.33% 92 / 100   
1 Year 35.23% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog